Your browser doesn't support javascript.
loading
Efficacy and Safety of Dulaglutide Monotherapy Compared to Glimepiride in Oral Antihyperglycemic Medication-Naïve Chinese patients with Type 2 Diabetes: A Post Hoc Analysis of AWARD-CHN1.
Li, Yi Ming; Zhang, Li Hui; Li, Xue Jun; Zhang, Bin; Hou, Jia Ning; Tong, Nan Wei.
Afiliación
  • Li YM; Department of Endocrinology, Huashan Hospital, Fudan University, Shanghai, 200040, China.
  • Zhang LH; Department of Endocrinology, The Second Hospital of Hebei Medical University, Hebei, 050000, China.
  • Li XJ; Department of Endocrinology and Diabetes, Xiamen Diabetes Institute, The First Affiliated Hospital of Xiamen University, Xiamen, 361000, China.
  • Zhang B; Lilly Suzhou Pharmaceutical Co., Ltd Shanghai Branch, No. 288 Shimen No.1 Road, Jingan District, Shanghai, 200041, China.
  • Hou JN; Lilly Suzhou Pharmaceutical Co., Ltd Shanghai Branch, No. 288 Shimen No.1 Road, Jingan District, Shanghai, 200041, China. hou_jia_ning@lilly.com.
  • Tong NW; Division of Endocrinology and Metabolism, West China Hospital of Sichuan University, Sichuan, 610041, China. tongnw@scu.edu.cn.
Diabetes Ther ; 11(5): 1077-1090, 2020 May.
Article en En | MEDLINE | ID: mdl-32219675
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Guideline Idioma: En Revista: Diabetes Ther Año: 2020 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Guideline Idioma: En Revista: Diabetes Ther Año: 2020 Tipo del documento: Article País de afiliación: China